ArticleInfectious diseases and therapy2025
The Risk of Herpes Zoster in Patients with Depressive Disorders: A German Claims Database Analysis.
Article in Infectious diseases and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Letter to the Editor Regarding "The Risk of Herpes Zoster in Patients with Depressive Disorders: A German Claims Database Analysis".Infectious diseases and therapy · 2026Article
- A Response to: Letter to the Editor Regarding "The Risk of Herpes Zoster in Patients with Depressive Disorders: A German Claims Database Analysis".Infectious diseases and therapy · 2026Article
- No Evidence for a Causal Association Between Depression and Herpes Zoster or Post-Herpetic Neuralgia: A Mendelian Randomization Study.Journal of pain research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionPatients with depression were shown to be at increased risk of herpes zoster (HZ). However, an in-depth description of depression as a risk factor for HZ, postherpetic neuralgia (PHN), and HZ recurrence is lacking. The goal of this study was to quantify the risk of HZ, PHN, and HZ recurrence in people with depression and among depression-related subgroups in Germany.
methodsUsing health insurance claims data from 2012 to 2021 from a large German claims database, people ≥ 18 years old diagnosed with depression were identified and matched to control persons without depression using a rolling cohort design. Incidence rates (cases per 1000 person-years [PYs]) and incidence rate ratios (IRRs) were calculated using Poisson models.
resultsOverall, 1,768,701 people with depression were matched to controls without depression. HZ incidence rates were higher in people with depression (10.51 cases/1000 PYs) than in people without depression (9.04 cases/1000 PYs). Overall, people with depression had a significantly increased risk of HZ (IRR = 1.16; p < 0.0001), PHN (IRR = 1.16; p < 0.0001), and HZ recurrence (IRR = 1.22; p < 0.0001). IRRs were highest in the 18 to 49 years age group (IRR HZ = 1.24; p < 0.0001; IRR PHN = 1.35; p < 0.0001). IRRs for HZ were highest in people with mental disorder comorbidities (IRR = 1.23; p < 0.0001).
conclusionsA diagnosis of depression is associated with an increased risk of HZ, PHN, and HZ recurrence. People with depression should be considered when developing HZ vaccination recommendations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.